LEADER 02079nam 22005293u 450 001 9910457427603321 005 20210114202625.0 010 $a1-280-94724-1 010 $a9786610947249 010 $a0-335-22644-2 035 $a(CKB)1000000000361509 035 $a(EBL)292114 035 $a(OCoLC)182530556 035 $a(SSID)ssj0000169554 035 $a(PQKBManifestationID)11177818 035 $a(PQKBTitleCode)TC0000169554 035 $a(PQKBWorkID)10215128 035 $a(PQKB)11444383 035 $a(MiAaPQ)EBC292114 035 $a(EXLCZ)991000000000361509 100 $a20130923d2004|||| u|| | 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aHealth Policy and European Union Enlargement$b[electronic resource] 210 $aMaidenhead $cMcGraw-Hill Education$d2004 215 $a1 online resource (311 p.) 300 $aDescription based upon print version of record. 311 $a0-335-21353-7 327 $aCover; Half title; Title; Copyright; Contents; Acknowledgements; Chapter 1; Chapter 2; Chapter 3; Chapter 4; Chapter 5; Chapter 6; Chapter 7; Chapter 8; Chapter 9; Chapter 10; Chapter 11; Chapter 12; Chapter 13; Chapter 14; Chapter 15; Chapter 16; Chapter 17; Chapter 18; Index 330 $aThe process of European Union enlargement has major implications for health and health care policy throughout Europe. This book focuses on the diversity of countries involved in this process and the challenges they face. It is for students of health policy, economics, public policy and management, as well as health managers and policy makers. 606 $aMedical policy 608 $aElectronic books. 615 4$aMedical policy. 676 $a362.1094 700 $aMckee$b Martin$0862088 702 $aMacLehose$b Laura 702 $aNolte$b Ellen 801 0$bAU-PeEL 801 1$bAU-PeEL 801 2$bAU-PeEL 906 $aBOOK 912 $a9910457427603321 996 $aHealth Policy and European Union Enlargement$92133814 997 $aUNINA LEADER 03769nam 2200613 a 450 001 9910643069303321 005 20230213211600.0 010 $a1-280-76878-9 010 $a9786613679550 010 $a0-470-71931-1 010 $a0-470-71682-7 035 $a(CKB)1000000000687593 035 $a(EBL)703777 035 $a(OCoLC)775867508 035 $a(SSID)ssj0000715113 035 $a(PQKBManifestationID)11477158 035 $a(PQKBTitleCode)TC0000715113 035 $a(PQKBWorkID)10700470 035 $a(PQKB)11335466 035 $a(MiAaPQ)EBC703777 035 $a(EXLCZ)991000000000687593 100 $a20740612d1962 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aCiba Foundation Symposium$b[electronic resource] $eBilharziasis : held in commemoration of Theodor Maximilian Bilharz /$fedited by G.E.W. Wolstenholme and Maeve O'Connor 210 $aLondon $cJ. & A. Churchill$d1962 215 $a1 online resource (462 p.) 225 1 $aCiba Foundation symposia 300 $aDescription based upon print version of record. 311 $a0-470-72275-4 320 $aIncludes bibliographical references and index. 327 $aBILHARZIASIS; Contents; Opening address by the Chairman: Bilharziasis as a national health problem in the United Arab Re-public; Population studies of intermediate hosts in relation to transmission of bilharziasis in East Africa; Aspects of the ecology of the intermediate hosts of Schistosoma monsoni interfering with the transmission of bilharziasis in; Population ecology and epidemiological problems; Discussion; The variability in morphology and anatomy of the bulinid snails in Egypt, with special reference to their transmission of S 327 $aThe significance of infra-specific taxonomy in bilharziasisDiscussion; The ro?le of animals as reservoirs of bilharziasis in Africa; Discussion; General Discussion; Some nutritional aspects of bilharziasis; Discussion; Clinical aspects of bilharziasis; Important achievements in the control of bilharziasis in New China; The pathognomy of bilharziasis: an unanswered question; Discussion; Schistosomal metabolic products in the diagnosis of bilharziasis; Acquired resistance to bilharziasis; Discussion 327 $aObservations in mice on the schistosomicidal properties of 1:7-bis(p-aminophenoxy)heptane in vivo and in vivo/in vitroTracer studies with antimony-I24 in man; The search for non-antimonial schistosomicides; Discussion; Comparative investigations of some molluscicides; The ro?le of molluscicides in combating bilharziasis; The use of molluscicides as a bilharziasis control measure in South Africa; Discussion; Bilharziasis control as an integral part of rural health services; The modification of habitats in the control of bilharziasis, with special reference to water resource development 327 $aDiscussionSummaries and recommendations of sub-sections; I. Transmission of bilharziasis in Africa; II. Immunological aspects of bilharziasis; III. Experimental bilharziasis; IV. Summary of the clinicopathological aspects of bilharziasis; V. Environmental control and the use of molluscicides 410 0$aCiba Foundation symposium. 606 $aSchistosomiasis$vCongresses 615 0$aSchistosomiasis 676 $a616.9/63 676 $a616.963 701 $aWolstenholme$b G. E. W$g(Gordon Ethelbert Ward)$063039 701 $aO'Conner$b Maeve$01275287 701 $aBilharz$b Theodor$f1892-1962.$01275288 712 02$aCiba Foundation. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910643069303321 996 $aCiba Foundation Symposium$93004924 997 $aUNINA